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Abstract
Background: Small GTPases of the Rho family are critical regulators of various cellular functions
including actin cytoskeleton organization, activation of kinase cascades and mitogenesis. For this
reason, a major objective has been to understand the mechanisms of Rho GTPase regulation. Here,
we examine the function of a novel protein, Scambio, which shares homology with the DH-PH
domains of several known guanine nucleotide exchange factors for Rho family members.
Results: Scambio is located on human chromosome 14q11.1, encodes a protein of around 181
kDa, and is highly expressed in both heart and skeletal muscle. In contrast to most DH-PH-domain
containing proteins, it binds the activated, GTP-bound forms of Rac and Cdc42. However, it fails
to associate with V14RhoA. Immunofluorescence studies indicate that Scambio and activated Rac3
colocalize in membrane ruffles at the cell periphery. In accordance with these findings, Scambio
does not activate either Rac or Cdc42 but rather, stimulates guanine nucleotide exchange on RhoA
and its close relative, RhoC.
Conclusion: Scambio associates with Rac in its activated conformation and functions as a guanine
nucleotide exchange factor for Rho.
Background
Rho family members including Rac, Cdc42, and Rho are
essential regulators of various cellular processes such as
actin cytoskeleton reorganization, mitogenesis, activation
of kinase cascades, transcriptional activation, and stimula-
tion of DNA synthesis [1-3]. Interestingly, these small
GTPases have been implicated in oncogenesis, through
multiple approaches [4-10]. Like all members of the Ras
superfamily, Rho proteins function as molecular switches.
They characteristically cycle between an active, GTP-
bound state and an inactive, GDP-bound state. Switching
between these states is mediated by guanine nucleotide
exchange factors (GEFs) which promote the exchange of
bound GDP for GTP and thereby activate the small
GTPase [1]. The Dbl family of GEFs for Rho GTPases are
characterized by the presence of a Dbl homology (DH)
domain in tandem with a Pleckstrin homology domain
(PH). While the DH domain catalyzes guanine nucleotide
exchange, the PH domain is essential for membrane local-
ization via phospholipid binding [11]. The prototype DH-
PH domain-containing protein, the Dbl proto-oncogene,
was originally isolated as a transforming gene from a
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diffuse B-cell lymphoma, and was later shown to release
GDP from Cdc42 [11]. Furthermore, other Dbl-like GEFs
such as Vav, Tiam, Ost, and Dbs have also been demon-
strated to cause cellular transformation via their activation
of Rho family proteins or through the amplification of sig-
naling cascades [5,6,9,11]. Therefore, the study of these
regulators is likely to reveal crucial details of cellular
homeostasis and its disruption in cancer.
To date, three Rac proteins with an overall homology of
around 90% have been identified in man. Amongst these,
Rac2 is hematopoietic specific and involved in the oxida-
tive burst, whereas Rac1 and Rac3 are ubiquitously
expressed [1,12]. To elucidate the cellular functions of
Rac3 in relation to its downstream effectors, we have per-
formed a yeast two-hybrid screen using constitutively
active Rac3 as bait. Here we report the identification of a
novel protein that functions as both a binding partner for
activated Rac and a guanine nucleotide exchange factor
for Rho.
Results
Clone 78-3 represents a gene located on human 
chromosome 14q11.1 that is highly expressed in heart and 
skeletal muscle
To identify downstream targets of Rac3, we performed a
yeast two-hybrid screen of a human placental cDNA
library using constitutively active V12Rac3, with an S189
mutation at the carboxyl-terminal end to prevent lipid
modification and membrane targeting, as bait [13]. One
gene was isolated twice independently as clones 78-3 and
54-5. Clone 78-3 included a stop codon at its carboxyl-ter-
minus, whereas clone 54-5 contained an open reading
frame segment of the same gene (also see Fig. 4B). We
then isolated a full-length cDNA clone, from a human
kidney carcinoma (A498) cell line cDNA library. The open
reading frame of that clone (clone 4) predicted a protein
of 1519 amino acids length, with a calculated molecular
mass of 181 kDa (Fig. 1A) of which the amino acid
sequence (accession number BAB84883) was previously
deposited in Genbank by the Kazusa DNA Research
Institute.
A panel of somatic cell hybrid DNAs that each retain one
intact human chromosome was used to localize 78-3 to
chromosome 14 (data not shown). The gene spans 19.2
kb and includes 24 exons (Fig. 1B). The first exon encodes
the 5'-untranslated region and the first amino acid resi-
due. Exon 24 contains only 3'-untranslated sequences.
To examine if we had isolated a complete cDNA, Northern
blot analysis was performed on RNA from the human cell
lines HL-60 (promyelocytic leukemia) and SCaBER (blad-
der carcinoma). Using the entire cDNA insert of clone 4 as
probe, we detected a single mRNA of around 5.7 kb in
both cell lines, in close agreement with the combined
sizes of our cDNAs (Fig. 1C). Database searches with the
human cDNA sequence revealed that homologues of this
protein have been evolutionarily conserved in mouse. RT-
PCR analysis performed on total RNA from 13 mouse tis-
sues including heart, lung, brain, liver, kidney, spleen,
bladder, intestine, ovaries, testis, stomach, small intestine
and muscle, demonstrated that this gene is ubiquitously
expressed (data not shown).
This analysis did not provide information with respect to
relative abundance levels of the product encoded by 78-3.
We therefore raised polyclonal antisera against a C-termi-
nal domain of 78-3. To further study the relative abun-
dance of this protein in various tissues, Western blot
analysis was performed using lysates from multiple
mouse tissues (Fig. 1D). CHO-K1 cells transfected with
either vector or HA-78-3 were included as a negative and
positive control, respectively. We examined lysates from
kidney, mammary gland tumour, spleen, lungs, skeletal
muscle, brain, thymus, heart, and bone marrow. As a
loading control, blots were incubated with anti-GAPDH
antibodies. The antibodies were able to detect a product of
approximately 181 kDa in the CHO-K1 cells transfected
with HA-78-3. A protein of approximately 181 kDa was
also highly expressed in both heart and skeletal muscle,
and was also present in the lungs, albeit at a lower level
(not visible in Fig 1D).
Clone 4 encodes a DH-PH-domain containing protein, 
Scambio
The deduced amino acid sequence of clone 4 was screened
for known motifs using the ProfileScan program. This
analysis showed that it contains a tandem DH-PH domain
in its carboxyl-terminal end (Fig. 1A). These domains are
characteristic for proteins that act as GEFs for members of
the Rho family of small GTPases. Therefore, we propose to
name this protein Scambio (scambio = "exchange" in Ital-
ian), abbreviated as Sabi. A BLAST database search
showed that the Scambio DH and PH domains are most
closely related to those of Dbl, Dbs and Trio. However,
Scambio is clearly more distantly related to this group
than Dbl, Trio and Dbs are to each other. Dbl and Sabi
share 24% and 33% homology in their DH and PH
domains, respectively (Fig. 2A and 2B).
Scambio binds to activated Racs or Cdc42
The original yeast two-hybrid positives of Scambio were
isolated using constitutively active V12S189Rac3 as bait.
Clone 78-3 did not interact with wild-type (S189Rac3)
Rac3 in yeast (data not shown). Since the original clones
encoded only part of Scambio, it was important to exam-
ine if Rac would interact with the complete protein. There-
fore, we co-expressed full length, HA-tagged Scambio
together with GST-tagged Rac3, N17Rac3, or V12Rac3 inMolecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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Cloning of Scambio Figure 1
Cloning of Scambio (A) Deduced amino acid sequence of Scambio. The DH (amino acids 1085–1253) and PH (amino acids 
1265–1372) domains are underlined with solid and dashed lines, respectively. The original yeast two-hybrid positive cDNA starts 
at amino acid 769, as indicated with an arrow. (B) Schematic representation of the human Scambio gene structure. The size of 
each of the 24 exons is indicated in nucleotides below the top schematic. The number of amino acid residues encoded by each 
exon is shown beneath the bottom schematic. (C) Northern blot analysis of human Scambio expression. RNAs are as indi-
cated. The filter was hybridized to a cDNA probe and washed to 2.5 × SSC at 65°C (left panel). An ethidium bromide-stained 
gel serves as a loading control (right panel). (D) Western blot analysis of lysates from various mouse tissues. HA-Sabi 
(Scambio), vector control transfected CHO-K1 lysates and tissue lysates as indicated (top panel) were immunoblotted with 
antibodies that recognize the C-terminal domain of 78-3. Blots were also incubated with anti-GAPDH antibodies as a loading 
control (bottom panel).Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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Sequence alignment of the DH and PH domains Figure 2
Sequence alignment of the DH and PH domains (A) DH domains. Residues 1085–1253 of Scambio (Sabi) were aligned 
with similar sequences of Dbl, Trio and Dbs. (B) PH domains. The PH domains of Dbl, Trio, and Dbs were aligned with resi-
dues 1265–1372 of Scambio (Sabi). Conserved amino acid residues are blue (identical residues in some aligned sequences, but 
not all), green (conservative substitutions) or red (identical residues in all aligned sequences). Non-homologous residues are 
shown in black.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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CHO-K1 cells. Complex formation was evaluated via
immunoprecipitation using a monoclonal anti-HA anti-
body and immunoblotting using polyclonal anti-Rac3
antibodies. As shown in Figure 3A (left panel), Scambio
specifically complexed with the V12Rac3 mutant but not
with N17Rac3, wild type Rac3 or the GST control. Thus,
the interaction between Rac3 and Scambio is GTP-
dependent.
To determine whether Scambio binds to other Rho family
proteins, COS-1 cells were transfected with HA-Scambio
and the GST-tagged, GTP-bound forms of Rac3, Rac1,
Rac2, Cdc42 and RhoA. The small GTPases were precipi-
tated using glutathione agarose and the presence of
Scambio was investigated using HA antibodies. As shown
in Figure 3B, Scambio clearly interacted with all three con-
stitutively active Rac proteins as well as with constitutively
active Cdc42. However, it did not complex with GTP-
bound V14RhoA. These data indicate that Scambio inter-
acts with Rac/Cdc42 in vivo when these proteins are in
their GTP-bound conformation.
Active Rac3 colocalizes with Scambio and binds within a 
region containing its DH-PH domain
We next investigated in which location Scambio and Rac
interact within the cell. We expressed HA-tagged Scambio
together with activated Xpress-tagged Rac3 in NIH3T3
cells that were plated on fibronectin. After 24 hrs, the loca-
tions of V12Rac3 and Scambio were examined using
immunofluorescence and confocal microscopy. As shown
in Figure 4A, middle panel, V12Rac3 localized promi-
nently to the cell periphery and was especially concen-
trated in actin-based membrane ruffles. Similarly,
Scambio was present at the same locations, as indicated in
the individual (left panel) and merged image (Fig. 4A,
right panel, arrowheads).
We also examined which domain in Scambio mediates
the interaction with activated Rac3. The finding that full-
length Scambio, 78-3, and 54-5 all bind to V12Rac3
already delineated the binding region to residues 769-
1412 (shown in Fig 4B). A construct including residues 1–
952 failed to bind V12Rac3, indicating that the N-termi-
nal region of Scambio does not mediate Rac3 binding.
Surprisingly, a small segment containing residues 1076–
1510 did clearly interact with V12Rac3 (Fig. 4C). Thus,
V12Rac3 binds to a region in Scambio encompassed by
residues 1076–1412, which includes the DH-PH domain.
Scambio does not activate Rac and Cdc42
The finding that Scambio contains a DH-PH domain sug-
gests that it functions as a guanine nucleotide exchange
factor for Rho family members. To assess whether
Scambio could increase the levels of activated Rac3 and
Cdc42, we employed a recombinant GST-fusion protein
containing the isolated GTP-dependent binding domains
of the Rac and Cdc42 effector Pak1 [14]. CHO-K1 cells
were transiently transfected with either Xpress-Rac3 or
Xpress-Cdc42 or were co-transfected with HA-Sabi. Cells
were serum-starved in 0.1% FCS for 24 hrs to induce qui-
escence. As a positive control, GST-tagged oncogenic Dbl
(the Dbl-DH-PH domain) was co-expressed with either
Xpress-Rac3 or Xpress-Cdc42. The GST-pull downs, which
represent the GTP-bound fraction of the small GTPase,
Scambio interacts specifically with the constitutively activated  forms of Rac1, Rac2, Rac3 and Cdc42, but not with V14RhoA Figure 3
Scambio interacts specifically with the constitutively 
activated forms of Rac1, Rac2, Rac3 and Cdc42, but 
not with V14RhoA (A)CHO-K1 cells were transfected 
with HA-Sabi and GST only or GST-tagged wild type Rac3, 
N17Rac3, or V12Rac3. Scambio was immunoprecipitated 
using monoclonal anti-HA antibodies and complexed GST-
tagged Rac3 mutants were detected using polyclonal Rac3 
antibodies. Western blot analysis is shown of 7.5 µg of 
lysates (right panel) or immunoprecipitates from 0.4 mg of 
lysates (left panel). (B) COS-1 cells were transfected with 
HA-Scambio and the indicated constitutively active, GST-
tagged small GTPases. GST-tagged proteins were pulled 
down using glutathione-agarose beads. Scambio was detected 
using anti-HA antibodies and GST-tagged GTPases using anti-
GST antibodies. Western blot analysis is shown of 10 µg of 
lysate (right panel) or pull-down from 0.5 mg of lysate (GST-
PD, left panel). The sizes of RhoA and Cdc42 are larger 
because these proteins also contain a Myc tag.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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Activated Rac3 colocalizes with Scambio to membrane ruffles and binds to residues 1076–1412 of Scambio Figure 4
Activated Rac3 colocalizes with Scambio to membrane ruffles and binds to residues 1076–1412 of Scambio (A) 
NIH3T3 cells were co-transfectedwith HA-tagged Scambio and Xpress-tagged V12Rac3. Fibronectin adhered cells were 
stained for FITC-HA-Scambio (left panel), and Cy3-Xpress-V12Rac3 (middle panel), or merged (right panel). Arrowheads in the 
right panel point to the numerous ruffles where HA-Scambio and Xpress-V12Rac3 colocalize. Confocal images (× 100), Bar = 
20 µm. One cell is shown that is representative of many others obtained in more than two independent experiments. (B) Sche-
matic representation of the clones tested for binding to V12Rac3. Abbreviations used include; HA, hemagglutinin tag; DH, Dbl 
homology domain; and PH, pleckstrin homology domain. The DH and PH domains are shaded grey and black, respectively. (C) 
Activated Rac3 binds to a region encompassing the DH-PH domain of Scambio. The DH-PH domain-containing construct 
including a C-terminal Myc tag was co-transfected with GST-V12Rac3. Binding of this domain to GST-V12Rac3 was assessed 
on a GST pull-down of the lysate followed by an anti-Myc Western blot.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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were immunoblotted with anti-Xpress antibodies. As
shown in Fig. 5A and 5B, we were unable to detect
increased levels of Rac-GTP or Cdc42-GTP upon expres-
sion with Sabi, whereas in the positive control samples,
elevated levels of GTP-Rac and GTP-Cdc42 were clearly
present when they were co-expressed with Dbl. This result
was not unexpected. Since Rac and Cdc42 bind to
Scambio in their GTP-bound conformation, Scambio is
unlikely to act as an exchange factor for these small
GTPases.
Scambio activates RhoA and RhoC
As mentioned above, V14RhoA does not bind to Scambio.
This suggests that Scambio could function as a GEF for
RhoA or other Rho subfamily members. To address this,
we utilized a GST-fusion protein containing the Rhotekin
Rho-binding domain as an affinity reagent in a pull-down
assay, as described by Ren et al. [15] to determine whether
Scambio could increase the level of GTP-bound RhoA in
CHO-K1 cells. CHO-K1 cells were transiently transfected
with either Xpress-RhoA, Xpress-RhoC or were co-trans-
fected with HA-Scambio. Cells were serum-starved in
0.1% FCS for 24 hrs to induce quiescence, and immedi-
ately prior to lysis, cells were stimulated with 10% FCS for
one minute or were further serum deprived. As a positive
control, GST-tagged oncogenic Dbl was co-expressed with
Xpress-RhoA. The GST-pull downs (Fig. 6, upper panel)
and lysates (middle panel) which represent GTP-Rho and
total Rho, respectively, were immunoblotted with anti-
Xpress antibodies.
Scambio does not stimulate guanine nucleotide exchange on  Rac and Cdc42 Figure 5
Scambio does not stimulate guanine nucleotide 
exchange on Rac and Cdc42 (A) Cells were transiently 
transfected with either vector, wild type Rac3 (Xpress-
tagged), wild type Rac3 and Dbl, or wild type Rac3 and Sabi. 
The GST-pull downs (left panel) were immunoblotted with 
anti-Xpress antibodies. Lysates (right panel) were immunob-
lotted with anti-Xpress, anti-HA, and anti-GST antibodies to 
detect Xpress-tagged Rac3, HA-Sabi, and GST-Dbl, respec-
tively. (B) Cells were transfected with either vector alone, 
wild type Cdc42 (Xpress-tagged), wild type Cdc42 and Dbl 
or wild type Cdc42 and Sabi. The GST-pull downs for Cdc42 
(left panel) and lysates (right panel) were treated as described 
for Rac3.
Scambio stimulates guanine nucleotide exchange on RhoA  and RhoC Figure 6
Scambio stimulates guanine nucleotide exchange on 
RhoA and RhoC Cells were transfected with RhoA and 
vector (lanes 1, 2), with RhoA and Dbl (lanes 3, 4), with 
RhoC and vector (lanes 5, 6), with RhoC and Scambio (lanes 
7, 8) or with RhoA and Scambio (lanes 9, 10). Cells were 
stimulated with either 10% fetal calf serum for one minute 
(indicated as + below the panel) or were further serum-
starved immediately prior to lysis (indicated as -). The 
amount of GTP-Rho and total Rho was quantitated by immu-
noblotting with anti-Xpress antibodies on the pull-down 
(upper, GTP-Rho) or 1.7% of the total cellular lysate (middle, 
total Rho). Equal application of GST-RBD in the Rhotekin pull 
down assay is shown by staining of the gel with Coomassie 
Brilliant Blue (bottom, GST-RBD). The fold activation was 
determined by normalizing the GTP-Rho levels to total Rho 
levels and was measured relative to the level of activation 
seen for the control, using densitometric quantification. Simi-
lar results were obtained in more than two other independ-
ent experiments.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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As expected, the expression of oncogenic Dbl increased
the GTP levels of co-transfected RhoA as compared to cells
transfected with the vector control (Fig. 6, compare lane 1
to lanes 3 and 4). Interestingly, Scambio also clearly stim-
ulated guanine nucleotide exchange on RhoA: an increase
in Rho-GTP levels of 3.2 and 5.2-fold was found upon
serum-starvation and serum stimulation respectively, in
comparison with vector and RhoA transfected cells (Fig. 6,
compare lane 1 to lanes 9 and 10). We also tested the
activity of Scambio towards RhoC, a small Rho family
GTPase, which is closely related to RhoA but has been less
intensively studied. We found that Scambio was able to
stimulate the activation of RhoC relative to the control
(compare lane 5 to lanes 7 and 8) when HA-Scambio and
Xpress-RhoC were co-expressed. These data demonstrate
that Scambio acts as a guanine nucleotide exchange factor
for both RhoA and RhoC.
Scambio stimulates guanine nucleotide exchange on 
endogenous Rho
In the experiments described above, Scambio activated
both RhoA and RhoC when these small GTPases were
overexpressed. To determine whether Scambio also acts as
a GEF on physiologically relevant levels of Rho proteins,
we assayed for increased levels of endogenous GTP-Rho in
the presence of Scambio.
CHO-K1 cells transfected with either vector or Scambio
were serum-starved, then stimulated with 10% fetal calf
serum (FCS) for varying durations of time prior to assay-
ing for levels of GTP-bound Rho. Rho activation was
detected with a monoclonal antibody directed against an
epitope common to different Rho proteins. As shown in
Figure 7A, increases in Rho-GTP levels stimulated by
Scambio after serum stimulation were transient, reaching
maximal levels after one minute. We also compared the
ability of Scambio to promote GTP-loading on endog-
enous Rho to that of oncogenic Dbl. As shown in Figure
7B, expression of Scambio caused substantial increases in
the levels of endogenous Rho, albeit at a slightly lower
level than that of the Dbl oncogene. These findings, in
conjunction with those described above, indicate that
Scambio acts as a GEF for both overexpressed and endog-
enous Rho.
Discussion
In this study, we have characterized Scambio, a novel
nucleotide exchange factor of the Dbl family. Scambio
contains a tandem DH-PH domain, the classical hallmark
of a GEF for Rho family proteins. Within the Dbl family,
some members act exclusively on specific small GTPases,
whereas others are more promiscuous [16]. Our data indi-
cate that Scambio functions as a guanine nucleotide
exchange factor for RhoA and RhoC, but does not activate
Rac or Cdc42. Thus, Scambio belongs to the class of Rho-
GEFs with specificity for a subset of Rho-related small
GTPases.
RT-PCR analysis indicated that Scambio is ubiquitously
expressed. However, this non-quantitative assay did not
allow us to determine relative expression levels. Therefore,
we raised antisera and performed Western blot analysis of
multiple mouse tissue lysates. This revealed that the
Scambio protein is highly expressed in heart and skeletal
muscle, and, to a lesser extent, in the lungs. This finding
suggests that it has an important function in these tissues.
Scambio activates endogenous Rho Figure 7
Scambio activates endogenous Rho (A) Kinetics of Rho 
activation by Scambio. CHO-K1 cells were transfected with 
either vector (indicated as a – below the panel) or with 
Scambio (indicated with a +), serum-starved and then stimu-
lated with 10% serum for the number of minutes indicated 
above the panel. (B) Comparison of activation of endogenous 
Rho by Dbl and by Scambio. Cells were transfected with vec-
tor (lanes 1, 2), Dbl (lanes 3, 4) or Scambio (lanes 5, 6) and 
the levels of activated Rho determined as described in the 
legend to Fig. 6. The amount of GTP-Rho was quantitated by 
immunoblotting using a monoclonal antibody that recognizes 
an epitope common to Rho. Similar results were obtained in 
more than two other independent experiments.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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Interestingly, substantial evidence indicates that RhoA is
crucial to heart development and physiology [17-21].
RhoA has been shown to be highly up-regulated during
early heart development, is important for normal embry-
ogenesis [18], and has been implicated in the regulation
of hypertrophic cardiac muscle cell growth [19,22]. RhoA
also controls serum response factor (SRF) dependent car-
diac specific gene expression via interactions with the β1-
integrin signaling pathway and changes in actin cytoskel-
eton dynamics [17,20]. Furthermore, at least one RhoGEF
specific to cardiac cells has already been identified. The
p63Rho GEF, a RhoA specific, Dbl-like guanine nucle-
otide exchange factor, for example, has been shown to
induce stress fiber formation in fibroblasts and cardiac
myoblasts [21]. However, further experimentation will be
necessary to determine if Scambio is also involved in car-
diac development and contractility.
Scambio is unlike the majority of Dbl family members in
that it can bind to activated GTP-bound Rac and Cdc42.
Interestingly, the closely related GEF, Ost, which activates
both RhoA and Cdc42, also binds to activated Rac1. The
downstream effects of this binding are not known, but it
was suggested that Ost functions as a Rac effector and
links pathways involving Rac, Cdc42 and RhoA [23]. GEF-
H1 is a second GEF capable of binding to the GTP-bound
form of small Rho family GTPases. Unlike Scambio, it
binds both activated Rac and Rho, and is additionally able
to activate them. It is thought that this GEF may function
to transport and activate Rac at microtubules [24,25]. The
Lfc protein which binds to Rac in a nucleotide-independ-
ent manner but does not activate it, has also been sug-
gested to function to recruit Rac to microtubuli [26].
We have not found evidence that Scambio colocalizes
with microtubuli (LH, unpublished observations).
However, Scambio does contain a PH domain. These
domains can function as regulated membrane-binding
modules that bind to inositol lipids and respond to
upstream signals by targeting the host proteins to their
proper cellular location [27]. Therefore, the finding that
activated Rac and Scambio precisely colocalize at the cell
periphery in ruffles of cells that are adhering to
fibronectin suggests that Scambio recruits activated Rac to
a specific subcellular location.
The activity of many Dbl family GEFs is regulated. For
example, Vav is activated by tyrosine phosphorylation
[28,29]. We investigated the possible activation of
Scambio by overexpressing it with a constitutively active
tyrosine kinase, Bcr/Abl [30], but did not detect increased
GEF activity (data not shown). Hyperosmotic stress has
been reported to activate Rho in a kidney tubular epithe-
lial cell line [31]. In concordance with these results, we
could detect Rho activation in CHO-K1 cells upon hyper-
tonic treatment, but this did not increase the Scambio-
mediated Rho activation. Cold stress also failed to
increase Rho activation through Scambio (data not
shown).
We found that Scambio had detectable GEF activity when
expressed in serum-starved cells without any stimulation
by external factors. Interestingly, stimulation of cells that
had been serum-starved, using fetal calf serum, caused a
very rapid and transient increase in the exchange factor
activity of Scambio, indicating that it is regulated by a
component of serum such as growth factors or lysophos-
phatidic acid (LPA). Since Scambio has been demon-
strated to activate both RhoA and RhoC and because
many cancers are characterized by deregulation of
mitogenic signals via such small GTPases, it is possible
that this exchange factor plays a role in certain malignan-
cies. It will therefore be of interest to examine if any muta-
tions can constitutively activate the GEF activity of
Scambio towards Rho.
Conclusions
Scambio is encoded by a novel gene that is highly
expressed in heart and skeletal muscle. It binds to Rac and
Cdc42 in a GTP dependent manner, but does not activate
them. Scambio functions to promote the activation of
RhoA and RhoC, by acting as a guanine nucleotide
exchange factor. Further studies will be important in elu-
cidating the mechanism by which Scambio integrates
these dual functions and in understanding how Scambio




We screened a human placental cDNA library (MATCH-
MAKER, Clontech) with V12S189Rac3 as previously
described [13]. One of 10 positives recovered in this
screen was clone 78-3, which was isolated independently
twice. Candidate positive cDNAs from the yeast two-
hybrid screen were subcloned into pSK (Stratagene) and
sequenced. The 3.1 kb cDNA clone 78-3 encodes 750
amino acids (residues 769–1519 of Scambio) and has 50-
bp of 3'-untranslated sequences. cDNA clone 54-5, with a
3.2 kb insert, encodes 1077 amino acid residues (residues
321–1412 of Scambio). We screened a human kidney car-
cinoma (A498) cell line cDNA library using clone 78-3 as
a probe to obtain a full-length cDNA. Two positives were
isolated of 5.2 kb (clone 4) and 5.7 kb (clone 11). The lat-
ter had a longer 3'-untranslated region and a deletion,
which caused a frame shift. Clone 4 contained the com-
plete coding region, including a Kozak sequence,
CCATGG, flanking the ATG initiator codon and is referred
to as full-length Scambio. The clone also contains 100 bp
of 5'-noncoding and 530 bp of 3'-untranslated sequences.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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The amino acid sequence of a clone identical to Scambio,
isolated from a human spleen cDNA library, has been
reported (locus BAB84883; gi: 18676462; nt sequence
AK074057, gi: 18676461). This gene is located on a contig
on chromosome 14q11.1 (NT_026437). Our original
yeast clone (78-3) was digested with EcoRIxXhoI, and
subcloned into pSG5. This construct contains an N-termi-
nal HA-epitope tag from pACT-2. HA-78-3 expresses an
84-kDa protein. We subcloned the full-length HA-tagged
Scambio into pSG5 and pIRESneo (Clontech). The calcu-
lated size of the protein product is 181 kDa. Additional
deletion mutants include HA-Scambio C (1–952) in
pIRESneo (110 kDa) and Scambio-DH-PH-Myc in
pcDNA (50 kDa).
Plasmids
The plasmids pAS2-1/V12S189Rac3, pAS2-1/S189Rac3,
pLEF/GST-wtRac3, pLEF/GST-V12Rac3, pLEF/GST-
N17Rac3, pLEF/GST-V12Rac1, pLEF/GST-V12Rac2, pLEF/
GST-V12Cdc42, pLEF/GST-V14RhoA, and pcDNA3.1/
Xpress-V12Rac3 have been described previously [13,32].
Wild type RhoA and RhoC in pcDNA3.1 were from the
Guthrie Research Institute. pcDNA3.1/RhoA and
pcDNA3.1/RhoC were digested with EcoRIxXbaI, and
subcloned into pcDNA3.1 (Invitrogen), which provides
an Xpress-tag. For pIRESneo/HA-Scambio, full length HA-
Scambio was subcloned into pSG5 and a 5.2 kb EcoRI
fragment from this construct was inserted into pIRESneo
(Clontech). Oncogenic Dbl was a gift from Dr. S.A. Aaron-
son (Mount Sinai School of Medicine, New York, NY).
pZIP-Dbl was digested with BamHI, and a 1.8 kb fragment
was inserted into pLEF [33]. GST-RBD was kindly pro-
vided by Dr. M.A. Schwartz (The Scripps Research Insti-
tute, La Jolla, CA). GST-Pak-RBD was a gift from Dr. Ulla
Knaus (The Scripps Research Institute, La Jolla, CA).
Northern blotting, RT-PCR, and multiple tissue Western 
blotting
Total cell line RNA (15 µg) from the human bladder car-
cinoma SCaBER and promyelocytic leukemia HL-60
(ATCC) was run on a guanidine thiocyanate-agarose gel,
blotted and hybridized using standard protocols. Blots
were washed to 2.5 × SSC at 65°C. For RT-PCR of total
mouse RNAs (1 µg per reaction), we selected as forward
primer (in human, located in exon 2): 5'-CGCCCTTT-
GAAGCCACAGCC-3' and reverse primer (in human, in
exon 3): 5'-TCCTGTACCCGCCCACCTCC-3', which, in
human are separated by an intron. These primers corre-
spond approximately to amino acid residues 19–133 in
the human sequence and are predicted, based on the
human sequence, to give a 345 bp product. Tissue lysates
in SDS sample buffer obtained from mouse kidney, mam-
mary gland tumour, spleen, lungs, skeletal muscle, brain,
thymus, heart, and bone marrow were immunoblotted
with antibodies that recognize the C-terminal domain of
78-3 (anti-78-3, 1:500). These polyclonal antibodies were
raised in rabbit against a C-terminal region of 78-3 includ-
ing amino acid residues 952–1265 expressed as a GST
fusion protein in pGEX-3X. CHO-K1 cells transfected with
6 µg of either vector or HA-78-3 were included as a nega-
tive and positive control, respectively. As a loading con-
trol, blots were incubated with monoclonal anti-GAPDH
antibodies (Chemicon, 1:10,000).
Interaction of small GTPases with Scambio in eukaryotic 
cells
CHO-K1 cells (ATCC) were transiently transfected with a
total of 6 µg DNA, with full length, HA-tagged Scambio
together with GST tagged wild type Rac3, N17Rac3, or
V12Rac3. As a negative control, cells were transfected with
GST alone. Scambio was immunoprecipitated from 0.4
mg of lysates using monoclonal anti-HA antibodies (USC
core facility, 1:1000) and complexed GST-tagged Rac3
mutants were detected using polyclonal Rac3 antibodies
([12], 1:1000). Western blot analysis was performed using
7.5 µg of lysate.
COS-1 cells (ATCC) were transiently transfected with 5.5
µg of pSG5/HA-tagged-Scambio and 0.5 µg of GST-fusion
protein-expressing pLEF using Lipofectamine. pLEF plas-
mids included pLEF/GST-V12Rac1, pLEF/GST-V12Rac2,
pLEF/GST-V12Rac3, pLEF/GST-V12Cdc42, pLEF/GST-
V14RhoA, or pLEF-vector plasmid. Transfected cells were
lysed in Triton-lysis buffer (25 mM sodium phosphate,
pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100, 50
mM NaF, 1 mM PMSF, 10 µg/ml aprotinin, 10 µg/ml leu-
peptin, 1 µM pepstatin, and 1 mM Na3VO4) and cleared
lysates (0.5 mg) were incubated with glutathione agarose
beads as described [13]. GST-containing proteins were
immobilized on glutathione agarose, and the presence of
Scambio and GST-fusion proteins were detected with anti-
HA (USC core facility, 1:1000) and polyclonal anti-GST
(1:2000) antibodies. Proteins were visualized using ECL
(Amersham).
Immunocytochemistry
NIH3T3 cells (ATCC) were transfected with a total of 6 µg
of plasmid DNA encoding either HA-tagged full-length
Scambio or with Xpress-tagged V12Rac3 using
Lipofectamine (Invitrogen). Twenty-four hrs post trans-
fection, cells were trypsinized and allowed to adhere to
fibronectin (Sigma)-coated chamber slides (Nalge Nunc)
for 24 hrs. Transfected cells were washed twice with phos-
phate buffered saline (PBS), fixed with 2% paraformalde-
hyde for 15 minutes, and permeabilized with 0.2% Triton
X-100 in PBS for 5 minutes. Cells were then washed three
times with PBS, twice with PBS/1% BSA, and blocked with
3% normal goat serum (Jackson Laboratories) in PBS for
30 minutes. Cells were immunostained with rabbit
polyclonal anti-HA antibodies (1:400, Santa Cruz) orMolecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/10
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monoclonal anti-Xpress (1:400, Invitrogen) antibodies
for 1 hr and washed four times with PBS. After incubation
with FITC-(1:50, Zymed), or Cy3-labeled (1:200, Jackson)
secondary antibodies for 30 minutes, cells were washed
three times with PBS, mounted using Vectashield (Vector
Laboratories), and analyzed with a Leica TCG SP confocal
microscope, or a Leica DM RA fluorescence microscope.
Purification of GST-Pak-RBD and GST-RBD
The isolated GTP-dependent binding domains (amino
acids 70–132) of the Rac and Cdc42 effector Pak1 (p21
activated kinase) [14] were used to affinity-precipitate
activated GTP-Rac3 and GTP-Cdc42. GST-Pak-RBD purifi-
cation was similar to that described by Benard et al. [14].
The Rhotekin Rho binding domain (RBD, amino acids 7–
89) was used to affinity purify GTP-Rho. GST-RBD purifi-
cation was essentially as described by Ren et al. [15]. Cells
grown to an absorbance of 0.8 (A600) were induced for 3
hrs by the addition of 0.5 mM isopropyl B-D-thiogalato-
pyranoside (IPTG). Cells were suspended in 20 ml of ice-
cold lysis buffer (50 mM Tris, pH 7.5, 5 mM MgCl2, 150
mM NaCl, 1% Triton X-100, 1 mM DTT, 10 µg/ml apro-
tinin and leupeptin, and 1 mM PMSF), sonicated and
insoluble material removed by centrifugation. The GST-
RBD protein was bound to glutathione agarose beads
(Sigma) and the lysate-bead mixture was then washed six
times in 5 ml of wash buffer (50 mM Tris, pH 7.5, 5 mM
MgCl2, 150 mM NaCl, 0.5% Triton X-100, 1 mM DTT, 10
µg/ml aprotinin and leupeptin, and 0.1 mM PMSF). After
removing remaining supernatant, the beads were resus-
pended in 2 ml wash buffer and 10% glycerol and purified
GST-RBD was stored on beads in aliquots at -80°C.
Rac3 and Cdc42 GTPase activation assays
CHO-K1 cells were seeded onto 10 cm2 tissue culture
dishes in Dulbecco's modified Eagle's medium (DMEM) +
10% FCS. After 24 hrs, cells were transiently transfected
with either Xpress-Rac3 or Xpress-Cdc42 or were co-trans-
fected with HA-Scambio or vector. As a positive control,
cells were co-transfected with Xpress-Rac3 or Xpress-
Cdc42 plus GST-Dbl-DH-PH. After 18 hrs, cells were
serum-starved in 0.1% FCS/DMEM for 24 hrs to induce
quiescence. Cells were washed twice in ice-cold PBS (-/-)
and harvested by scraping into 500 µl of lysis buffer (25
mM Tris-HCl, pH 7.5, 5 mM MgCl2, 100 mM NaCl, 1%
Igepal, 5% (v/v) glycerol, 1 mM Na3VO4) [14]. Cells were
incubated on ice for 20 min. Following centrifugation at
13,000 g for 10 min (4°C), 450 µl of supernatant was
incubated with 7.5 µl (30 µg) of GST-Pak-RBD precoupled
to glutathione agarose beads (Sigma) at 4°C for one hr.
An aliquot of supernatant was used to represent total pro-
tein levels. Beads were washed 4 times with 1 ml lysis
buffer (without 1 mM Na3VO4). Finally, GST-Pak-RBD
pull down samples or lysates were separated by SDS-
PAGE and were analyzed by immunoblotting with mono-
clonal anti-Xpress antibodies (Invitrogen, 1:5000) to
detect overexpressed Rho GTPases, monoclonal anti-HA
(USC core facility, 1:1000), and polyclonal anti-GST anti-
bodies (1:2000). Proteins were visualized using ECL
(Amersham) and developed on Hyperfilm (Kodak).
RhoA and RhoC GTPase activation assays
CHO-K1 cells were seeded onto 10 cm2 tissue culture
dishes in Dulbecco's modified Eagle's medium (DMEM) +
10% FCS. After 24 hrs, cells were transiently transfected
with either Xpress-RhoA or Xpress-RhoC, or were co-trans-
fected with HA-Scambio or vector. As a positive control,
cells were co-transfected with Xpress-RhoA plus GST-Dbl-
DH-PH. When assaying for endogenous Rho, cells were
transfected with vector, HA-Scambio or GST-Dbl-DH/PH
alone. After 18 hrs, cells were serum-starved in 0.1% FCS/
DMEM for 24 hrs to induce quiescence and immediately
prior to experimentation cells were either stimulated with
10% FCS/DMEM for one minute or were further starved.
Cells were washed twice in ice-cold TBS and harvested by
scraping into 600 µl of 50 mM Tris, pH 7.2, 10 mM MgCl2,
500 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.1% sodium
deoxycholate, 10 µg/ml aprotinin and leupeptin, and 1
mM PMSF. 750 µg-1 mg of cell lysates were clarified by
centrifugation at 13,000 g for 10 min at 4°C. The superna-
tant was then rotated with ~30 µg of GST-RBD precoupled
to glutathione agarose beads (Sigma) at 4°C for one hr.
Beads were washed four times in 600 µl of 50 mM Tris, pH
7.2, 10 mM MgCl2, 150 mM NaCl, 1% Triton X-100, 10
µg/ml aprotinin and leupeptin, and 0.1 mM PMSF.
Finally, GST-RBD pull downs and lysates were eluted in 2
× SDS sample buffer, separated by SDS-PAGE, and ana-
lyzed by immunoblotting with monoclonal anti-Xpress
antibodies (Invitrogen, 1:5000) to detect overexpressed
Rho GTPases or with a monoclonal anti-Rho antibody
(BD Transduction Laboratories, 1:250) that recognizes an
epitope common to different Rho proteins to detect
endogenous Rho. Proteins were visualized using ECL
(Amersham) and developed on Hyperfilm (Kodak). Densi-
tometric analysis of Rho activation levels was performed
using UnScan It Software (Silk Scientific).
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